C4 Therapeutics, Inc (CCCC) insider trading
Every open-market stock purchase and sale by C4 Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $22.2K over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Utpal Koppikar (Director), $31.7K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $22.2K (1 sale). Last close $3.85 on Jun 4, 2026.
Recent CCCC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | Utpal Koppikar (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Steven L. Hoerter (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Owen Hughes (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Ronald Harold Wilfred Cooper (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Stephen Fawell (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Donna Roy Grogan (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Laura Bessen (Director) | Bought (not open market) | — |
| Jun 24, 2026 | Kenneth Carl Anderson (Director) | Bought (not open market) | — |
| Jun 1, 2026 | Kenneth Carl Anderson (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Donna Roy Grogan (Director) | Bought (not open market) | $14.5K |
| Apr 1, 2026 | Kenneth Carl Anderson (Director) | Bought (not open market) | $11.5K |
| Feb 15, 2026 | Andrew Hirsch (CEO) | Sold (not open market) | $17.1K |
| Feb 15, 2026 | Andrew Hirsch (CEO) | Bought (not open market) | — |
| Feb 14, 2026 | Andrew Hirsch (CEO) | Sold (not open market) | $74K |
| Feb 14, 2026 | Leonard Reyno (C-suite exec) | Sold (not open market) | $31.3K |
| Feb 14, 2026 | Kendra Adams (CFO) | Sold (not open market) | $29.1K |
| Feb 14, 2026 | Scott N Boyle (C-suite exec) | Sold (not open market) | $13.7K |
| Feb 14, 2026 | Kelly Schick (C-suite exec) | Sold (not open market) | $13.7K |
| Feb 14, 2026 | Mark Mossler (C-suite exec) | Sold (not open market) | $6.2K |
| Feb 14, 2026 | Paige Mahaney (C-suite exec) | Sold (not open market) | $4.6K |
| Feb 14, 2026 | Mark Mossler (C-suite exec) | Bought (not open market) | — |
| Feb 14, 2026 | Paige Mahaney (C-suite exec) | Bought (not open market) | — |
| Feb 14, 2026 | Kelly Schick (C-suite exec) | Bought (not open market) | — |
| Feb 14, 2026 | Leonard Reyno (C-suite exec) | Bought (not open market) | — |
| Feb 14, 2026 | Andrew Hirsch (CEO) | Bought (not open market) | — |
Who's trading CCCC
- Steven L. Hoerter, Director: other filings, last Jun 24, 2026
- Donna Roy Grogan, Director: other filings, last Jun 24, 2026
- Laura Bessen, Director: other filings, last Jun 24, 2026
- Kenneth Carl Anderson, Director: other filings, last Jun 24, 2026
- Ronald Harold Wilfred Cooper, Director: other filings, last Jun 24, 2026
- Utpal Koppikar, Director: other filings, last Jun 24, 2026
- Owen Hughes, Director: other filings, last Jun 24, 2026
- Stephen Fawell, Director: other filings, last Jun 24, 2026
- Andrew Hirsch, CEO: other filings, last Feb 15, 2026
- Kendra Adams, CFO: other filings, last Feb 14, 2026
- Scott N Boyle, C-suite exec: other filings, last Feb 14, 2026
- Paige Mahaney, C-suite exec: other filings, last Feb 14, 2026
- Mark Mossler, C-suite exec: other filings, last Feb 14, 2026
- Leonard Reyno, C-suite exec: sold $22.2K (1 sale), last Feb 14, 2026
- Kelly Schick, C-suite exec: other filings, last Feb 14, 2026
Get free alerts when an insider at C4 Therapeutics, Inc files a new trade →